Carlos Perez Gonzalez

Carlos Perez Gonzalez

Auto-generated profile, based on publicly available information

Carlos Perez Gonzalez

Institut Curie, France

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2024 in Science
Verified
Journal Article
Closed access
MBMeryem B. Baghdadi
Meryem B. Baghdadi
RHRonja M. Houtekamer
Ronja M. Houtekamer
LPLouisiane Perrin
Louisiane Perrin
ARAbilasha Rao-Bhatia
Abilasha Rao-Bhatia
MWMyles Whelen
Myles Whelen
TKTae-Hee Kim
Tae-Hee Kim
Stem cells perceive and respond to biochemical and physical signals to maintain homeostasis. Yet, it remains unclear how stem cells sense mechanical signals from their niche in vivo. In this work, we investigated the roles of PIEZO mechanosensitive channels in the intestinal stem cell (ISC) niche. We used mouse genetics and single-cell RNA sequencing analysis to assess the requirement for PIEZO channels in ISC maintenance. In vivo measurement of basement membrane stiffness showed that ISCs reside in a more rigid microenvironment at the bottom of the crypt. Three-dimensional and two-dimensional organoid systems combined with bioengineered substrates and a stretching device revealed that PIEZO channels sense extracellular mechanical stimuli to modulate ISC function. This study delineates the mechanistic cascade of PIEZO activation that coordinates ISC fate decision and maintenance.

1 February 2022 in Current Opinion in Genetics & Development
Verified
Journal Article
Open access
CPCarlos Pérez-González
Carlos Pérez-González
GCGerardo Ceada
Gerardo Ceada
MMMarija Matejčić
Marija Matejčić
XTXavier Trepat
Xavier Trepat
The dizzying life of the homeostatic intestinal epithelium is governed by a complex interplay between fate, form, force and function. This interplay is beginning to be elucidated thanks to advances in intravital and ex vivo imaging, organoid culture, and biomechanical measurements. Recent discoveries have untangled the intricate organization of the forces that fold the monolayer into crypts and villi, compartmentalize cell types, direct cell migration, and regulate cell identity, proliferation and death. These findings revealed that the dynamic equilibrium of the healthy intestinal epithelium relies on its ability to precisely coordinate tractions and tensions in space and time. In this review, we discuss recent findings in intestinal mechanobiology, and highlight some of the many fascinating questions that remain to be addressed in this emerging field.

7 September 2022 in EMBO Molecular Medicine
Verified
Journal Article
Open access
JMJean‐Philippe Morretton
Jean‐Philippe Morretton
ASAnthony Simon
Anthony Simon
AHAurélie Herbette
Aurélie Herbette
JBJorge Barbazán
Jorge Barbazán
CPCarlos Pérez‐González
Carlos Pérez‐González
RBRenata Basto
Renata Basto
Centrosome amplification, the presence of more than two centrosomes in a cell is a common feature of most human cancer cell lines. However, little is known about centrosome numbers in human cancers and whether amplification or other numerical aberrations are frequently present. To address this question, we have analyzed a large cohort of primary human epithelial ovarian cancers (EOCs) from 100 patients. We found that rigorous quantitation of centrosome number in tumor samples was extremely challenging due to tumor heterogeneity and extensive tissue disorganization. Interestingly, even if centrosome clusters could be identified, the incidence of centrosome amplification was not comparable to what has been described in cultured cancer cells. Surprisingly, centrosome loss events where a few or many nuclei were not associated with centrosomes were clearly noticed and overall more frequent than centrosome amplification. Our findings highlight the difficulty of characterizing centrosome numbers in human tumors, while revealing a novel paradigm of centrosome number defects in EOCs.

10 October 2025 in bioRxiv
Verified
Preprint
Open access
CPCarlos Pérez-González
Carlos Pérez-González
DBDavid B. Brückner
David B. Brückner
MDMickael Di-Luoffo
Mickael Di-Luoffo
SRSophie Richon
Sophie Richon
RGRuchi Goswami
Ruchi Goswami
DVDanijela Matic Vignjevic
Danijela Matic Vignjevic
Phenotypic heterogeneity and plasticity drive tumor growth, metastasis, therapy resistance, and relapse. This heterogeneity is mainly interpreted as a response to external signals from the microenvironment. However, here we show that cancer cells also follow intrinsic self-organized programs that are sufficient to coordinate the spatiotemporal patterning of tumor cell states. By combining quantitative measurements in tumors and organoids with theoretical modeling, we reveal emergent mechanical gradients that orchestrate cell state transitions during colorectal tumor growth. Compression at the tumor center induces a transition from a fetal-like state into a cancer stem cell (CSC) state. The CSC compartment exhibits a characteristic size determined by tumor rheological properties. Once this size is surpassed, a translationally arrested apoptotic core emerges, triggering a shift from homogeneous proliferation to a hierarchical cell turnover. These findings uncover stereotyped programs of self-organization that likely cooperate with the microenvironment to shape tumor heterogeneity and plasticity.

15 November 2021
Verified
Dataset
Closed access
DVDanijela Vignjevic
Danijela Vignjevic
LPLouisiane Perrin
Louisiane Perrin
CGCarlos Perez Gonzalez
Carlos Perez Gonzalez
The small intestine is the main organ for nutrient absorption, and its extensive resection leads to malabsorption and wasting conditions referred to as short bowel syndrome (SBS). Organoid technology enables an efficient expansion of intestinal epithelium tissue in vitro1, but reconstruction of the whole small intestine, including the complex lymphovascular system, has remained challenging2. Here we generate a functional small intestinalized colon (SIC) by replacing the native colonic epithelium with ileum-derived organoids. We first find that xenotransplanted human ileum organoids maintain their regional identity and form nascent villus structures in the mouse colon. In vitro culture of an organoid monolayer further reveals an essential role for luminal mechanistic flow in the formation of villi. We then develop a rat SIC model by repositioning the SIC at the ileocaecal junction, where the epithelium is exposed to a constant luminal stream of intestinal juice. This anatomical relocation provides the SIC with organ structures of the small intestine, including intact vasculature and innervation, villous structures, and the lacteal (a fat-absorbing lymphatic structure specific to the small intestine). The SIC has absorptive functions and markedly ameliorates intestinal failure in a rat model of SBS, whereas transplantation of colon organoids instead of ileum organoids invariably leads to mortality. These data provide a proof of principle for the use of intestinal organoids for regenerative purposes, and offer a feasible strategy for SBS treatment.

3 March 2022
Verified
Dataset
Closed access
DVDanijela Vignjevic
Danijela Vignjevic
CGCarlos Perez Gonzalez
Carlos Perez Gonzalez
LPLouisiane Perrin
Louisiane Perrin
This study shows that collagen III induces dormancy in different types of cancer cells. The authors compared extracellular matrix (ECM) production by dormant and proliferative cancer cells and found that collagen III was dramatically increased in the dormant population. By combining different in vivo tumor models, they show that collagen III is sensed by DDR1 receptors to induce dormancy. There is a positive feedback loop by which DDR1 activation by collagen III induces the expression of collagen III through STAT1, reinforcing the dormancy state. Interestingly, collagen produced by cancer cells (and not the stroma) is sufficient to trigger dormancy. Cancer cells, thus, create their own niche to induce and maintain dormancy. This is a nice example of how the tumor ECM regulates cancer cell states and, therefore, tumor progression.